Cowen Managing Director Jamie Streator to Keynote Burrill’s Inaugural Pacific Northwest Life Sciences Conference

Burrill & Company today announced that Jamie Streator, managing director of Cowen and Company’s Health Care Investment Banking Group, will keynote The Pacific Northwest Life Sciences Meeting.

Mr. Streator will speak on the public market’s views of the life sciences sector, the challenges emerging companies face, and the changing outlook for them. This inaugural year of the conference will be held Tuesday, May 6, 2008 at the Benson Hotel in Portland, Oregon.

The Pacific Northwest is home not only to life sciences’ superstars, but also many of the industry’s most promising start-ups. Increasingly, companies in this enterprising region are developing technology for use beyond just human healthcare, embracing fields such as wellness, agriculture, biomaterials, and biofuels. This meeting focuses on the state of the biotech industry in the Pacific Northwest and worldwide. The challenges and opportunities, capital availability, and success stories are just a few of the topics on tap for this must-attend meeting for CEOs, scientists, business development executives, financiers, and anyone with an interest in biotechnology.

Mr. Streator is a Managing Director in Cowen and Company’s Health Care Investment Banking Group focusing on life sciences companies. Prior to joining Cowen, Mr. Streator was Managing Director, Head of Health Care Investment Banking at Susquehanna Financial Group. Prior to Susquehanna, Mr. Streator was with Thomas Weisel Partners, where he founded the Health Care Investment Banking Group, and served as Partner and Co-Head of Health Care Investment Banking. Mr. Streator also served as a Managing Director and Co-Head of Health Care Investment Banking at Hambrecht & Quist (now JPMorgan). He received his Bachelor of Arts from Princeton University in 1980 with a major in History and a Masters in Business Administration from The Wharton School of the University of Pennsylvania in 1985 with a major in Finance. The cost of the conference is $299. Registration is now available on the Burrill & Company website at http://burrillandco.com/bio/PNW08.

About Burrill & Company
Founded in 1994, Burrill & Company is a San Francisco-based global leader in life sciences with activities in Private Equity, Venture Capital, Merchant Banking and Media. The Burrill family of venture capital funds has over $950 million under management and its merchant banking business is one of the industry leaders in life sciences transactions. The company's 60 person scientific and business team, supported by its 40-person Advisory Boards, the strategic and financial network of its limited partners, and the close relationships developed with numerous life sciences companies and management, provide Burrill with unparalleled access and insight.

Burrill is the creator, sponsor and facilitator of over a dozen leading industry conferences worldwide and publishes a wide range of bio-intelligence reports including: The Personalized Medicine Report, The Stem Cell Report, and periodic newsletters covering Canada, China, Europe, India, Japan and Partnering/M&A. In association with the California Healthcare Institute, Burrill publishes The Journal of Life Sciences a bimonthly magazine and online at www.tjols.com. Burrill's flagship publication is its annual State of the Industry report, the most recent 21st Edition being Biotech 2007: Life Sciences—A Global Transformation. The 22nd Edition is entitled Biotech 2008: Life Sciences—A 20/20 Vision to 2020, available 1Q ‚08. These publications provide the latest insight, intelligence and information on the life sciences industry.